Therapeutic approaches for tumor necrosis factor inhibition
DOI:
https://doi.org/10.1590/S1984-82502011000300002Keywords:
Tumor necrosis factor, TACE, p38 MAPK, NF-κ, B, cAMP, Phosphodiesterase, Adenosine receptorAbstract
Tumor necrosis factor (TNF) consists of an inflammatory cytokine essential for homeostasis and organism defense. Despite its physiological relevance, both increased biosynthesis and release of TNF lead to the exacerbation of inflammatory and oxidative responses, which are related to the pathogenesis of a host of diseases of an inflammatory, autoimmune and/or infectious nature. In this context, effective therapeutic approaches for the modulation of TNF have been the focus of research efforts. Approximately one million individuals worldwide have been treated with biotechnological inhibitors of this cytokine, the so-called anti-TNF biopharmaceuticals. However, given the high risk of infection and the limitations related to cost and administration routes, new therapeutic approaches aimed at biological targets that directly or indirectly modulate the production and/or activation of TNF appear promising alternatives for the discovery of new anti-inflammatory and immunomodulatory orally active drugs and are therefore discussed in this paper.Downloads
Download data is not yet available.
Downloads
Published
2011-09-01
Issue
Section
Reviews
License
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
How to Cite
Therapeutic approaches for tumor necrosis factor inhibition . (2011). Brazilian Journal of Pharmaceutical Sciences, 47(3), 427-446. https://doi.org/10.1590/S1984-82502011000300002